Contact
Please use this form to send email to PR contact of this press release:
Epizyme Doses First Patient in Global Phase 2 Study Evaluating Tazemetostat in Mesothelioma
TO:
Please use this form to send email to PR contact of this press release:
Epizyme Doses First Patient in Global Phase 2 Study Evaluating Tazemetostat in Mesothelioma
TO: